Gary N Buell

Title: Innovations and Contributions of Gary N Buell

Introduction

Gary N Buell is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of purinergic receptors, particularly through his innovative patents. With a total of 8 patents to his name, Buell's work has implications for various medical conditions.

Latest Patents

One of his latest patents is titled "Methods of screening modulators of mammalian P2X7 purinergic receptors." This invention relates to a purinergic receptor, specifically the P2X receptor, and includes a nucleic acid encoding the P2X receptor. The patent outlines a method for screening compounds that can inhibit P2X activity, which may be useful in treating diseases such as arthritis, respiratory disorders, and neurodegenerative diseases. Another significant patent is "Method of screening for compounds that bind P2X receptor." This invention utilizes recombinant DNA technology to clone and express the P2X receptor, allowing for the preparation of antibodies and the screening of compounds for various diseases, including epilepsy, pain, and asthma.

Career Highlights

Throughout his career, Gary N Buell has worked with prominent companies in the pharmaceutical industry, including Glaxo Group Limited and Biogen, Incorporated. His experience in these organizations has contributed to his expertise in the field of receptor research and drug development.

Collaborations

Buell has collaborated with notable colleagues such as Nageswararao Movva and Annmarie Surprenant. These collaborations have likely enhanced his research and innovation efforts in the field of purinergic receptors.

Conclusion

Gary N Buell's contributions to the field of purinergic receptors through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.